Tharimmune Stock (NASDAQ: THAR) stock price, news, charts, stock research, profile.
You can purchase shares of Tharimmune (NASDAQ:THAR) through any online brokerage.
Other companies in Tharimmune’s space includes: Entero Therapeutics (NASDAQ:ENTO), Synaptogenix (NASDAQ:SNPX), Quoin Pharmaceuticals (NASDAQ:QNRX), NuCana (NASDAQ:NCNA) and TransCode Therapeutics (NASDAQ:RNAZ).
Tharimmune has a consensus price target of $17.00.
The stock price for Tharimmune (NASDAQ: THAR) is $2.05 last updated December 19, 2024 at 6:21 PM EST.
There are no upcoming dividends for Tharimmune.
Tharimmune’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Tharimmune.
Tharimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.